Stephen Blewitt
About Stephen Blewitt
Independent Class III Director at P10, Inc. (PX); age 65; appointed April 21, 2025; serves on the Compensation Committee. Background includes Chief Investment Officer (Private Markets) and Head of Private Markets at Manulife Investment Management (Oct 2018–Jun 2023). Education: B.A. University of Chicago; M.B.A. Boston University. The Board determined he is “independent” under NYSE rules.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Manulife Investment Management | Chief Investment Officer (Private Markets) & Head of Private Markets | Oct 2018 – Jun 2023 | Led global investment teams across private equity and credit, real estate, infrastructure, timber, and agriculture |
| Manulife Investment Management (U.S. PE & Credit) | Business Leader | ~20 years prior to CIO role (company disclosure: “almost 20 years”) | Built and led U.S. private equity and credit business |
External Roles
| Organization | Role | Tenure | Focus/Impact |
|---|---|---|---|
| Youth.Work.Connect., LLC | Co-founder | Sep 2024 – present | Mission-based org helping underserved high school youth build social capital for economic mobility |
Board Governance
- Committee assignments: Member, Compensation Committee; not a chair. Current Compensation Committee members are Tracey Benford (Chair), Travis Barnes, Stephen Blewitt, and Robert B. Stewart Jr.
- Independence: Board determined Blewitt is independent under NYSE rules.
- Lead Independent Director: Tracey Benford, appointed June 2024; presides over independent director executive sessions and acts as liaison. Executive sessions occur at least quarterly.
- Meetings and attendance: Board held 10 meetings in 2024; all directors serving in 2024 attended ≥75% except Travis Barnes (70%). Blewitt was appointed in 2025; 2024 attendance not applicable.
- Controlled company status: PX is a controlled company with board designation rights for RCP and TrueBridge groups; the company states it does not intend to rely on controlled-company exemptions.
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Annual retainer (non-employee directors) | $185,000 | Approved for 2025 |
| Committee chair fee | +$15,000 | Approved for 2025 |
| Lead independent director premium | +$50,000 | Approved for 2025 |
| 2024 director fees | $175,000 | Payable entirely in restricted stock; one-year vesting |
As an independent non-employee director in 2025, Blewitt is eligible for the 2025 director compensation schedule above.
Performance Compensation
| Metric/Condition | Detail | Applies to |
|---|---|---|
| Director equity vesting | RSU/restricted stock grants to non-employee directors vest on first anniversary of grant (2024 program) | Directors (company-wide) |
| Company clawback policy | 2023 adoption to recover erroneously awarded compensation in the event of an accounting restatement; aligns with SEC/NYSE rules | Executives; governance framework applies firmwide |
| Hedging/pledging | Insider trading policy prohibits hedging and pledging by directors, officers, employees | Directors (including Blewitt) |
No director performance-based metrics (e.g., EBITDA/TSR goals) are disclosed for directors at PX; director equity is service-based with time vesting.
Other Directorships & Interlocks
| Company | Role | Committee Roles | Interlocks / Related-party exposure |
|---|---|---|---|
| None disclosed in PX proxy | — | — | Proxy biography does not list other public company boards for Blewitt |
Expertise & Qualifications
- Private markets leadership across PE/credit, real assets, and alternatives; deep multi-asset experience from Manulife Investment Management.
- Education: B.A. University of Chicago; M.B.A. Boston University.
- Mission-focused external work via Youth.Work.Connect., supporting social mobility; useful stakeholder perspective for governance.
Equity Ownership
| As of Record Date (Apr 14, 2025) | Class A Shares | Class B Shares | Combined Voting Power |
|---|---|---|---|
| Stephen Blewitt | — | — | — |
Footnote confirms appointment to Board on April 21, 2025 (after the record date), explaining no reported beneficial ownership at that time.
- Director/officer investments: PX permits independent directors to invest alongside company funds up to a board-determined threshold without compromising independence (alignment with LPs), but amounts are reported on an aggregate basis; no Blewitt-specific investments are disclosed.
- Alignment policies: Anti-hedging/pledging policy supports alignment with shareholders.
Governance Assessment
- Positives: Independent director with deep private markets and multi-asset experience; sits on Compensation Committee, which oversees CEO and executive pay, equity plans, and incentive structures; presence of lead independent director and quarterly executive sessions bolster board effectiveness.
- Watch items: PX’s controlled company structure and dual-class voting concentrate control with Class B holders, which can dilute minority shareholder influence; however, PX states it does not intend to rely on controlled-company exemptions. Investors should monitor Compensation Committee rigor and director equity grant practices for alignment.
- Conflicts/related-party exposure: No Blewitt-specific related-party transactions disclosed. Company permits certain director investments in PX-managed funds under thresholds; Keystone/RCP relationships involve other directors, not Blewitt.
RED FLAGS: Company-level controlled-company dynamics and dual-class voting structure (concentrated voting power), not specific to Blewitt but relevant to governance risk.